Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Frits Van Rhee

Concepts (578)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
159
2024
2954
11.510
Why?
Antibodies, Monoclonal
26
2024
460
6.440
Why?
Hematopoietic Stem Cell Transplantation
28
2024
567
3.480
Why?
Antineoplastic Combined Chemotherapy Protocols
42
2024
990
3.380
Why?
Antineoplastic Agents
18
2024
1186
3.360
Why?
Humans
210
2024
50208
2.250
Why?
Thalidomide
24
2024
377
2.050
Why?
Monoclonal Gammopathy of Undetermined Significance
10
2024
115
1.940
Why?
Neoplasm Recurrence, Local
15
2024
613
1.880
Why?
Immunotherapy, Adoptive
9
2024
157
1.840
Why?
Killer Cells, Natural
8
2024
107
1.800
Why?
Transplantation, Autologous
26
2024
469
1.780
Why?
Interleukin-6
12
2023
265
1.700
Why?
Neoplasm Proteins
13
2022
324
1.630
Why?
Hematologic Neoplasms
3
2022
99
1.620
Why?
Middle Aged
72
2024
12206
1.500
Why?
Antigens, Neoplasm
6
2014
152
1.470
Why?
Clinical Trials as Topic
13
2022
466
1.460
Why?
Stem Cell Transplantation
10
2022
182
1.390
Why?
Prognosis
45
2024
1954
1.340
Why?
Gene Expression Regulation, Neoplastic
20
2022
828
1.300
Why?
Aged
72
2024
9405
1.300
Why?
Combined Modality Therapy
19
2024
636
1.280
Why?
Chromosomes, Human, Pair 1
9
2023
93
1.270
Why?
Herpesvirus 8, Human
7
2021
91
1.250
Why?
Translocation, Genetic
10
2022
264
1.200
Why?
Treatment Outcome
47
2024
5155
1.160
Why?
B-Cell Maturation Antigen
8
2024
91
1.150
Why?
Boronic Acids
12
2013
182
1.130
Why?
Pyrazines
12
2013
187
1.130
Why?
Adult
52
2024
13324
1.120
Why?
Male
82
2024
25399
1.120
Why?
Female
84
2024
26635
1.110
Why?
Bone Marrow
18
2024
363
1.070
Why?
Proteasome Inhibitors
5
2024
104
1.070
Why?
Antibodies, Bispecific
5
2024
69
1.030
Why?
Immunotherapy
6
2024
240
1.010
Why?
Gene Expression Profiling
26
2023
1037
1.010
Why?
Neoplasms, Second Primary
2
2024
78
1.000
Why?
Disease-Free Survival
24
2019
454
0.960
Why?
B-Lymphocytes
5
2024
170
0.940
Why?
Dexamethasone
14
2024
430
0.930
Why?
T-Lymphocytes, Cytotoxic
4
2014
65
0.910
Why?
Melphalan
9
2020
174
0.900
Why?
Cancer Vaccines
3
2010
78
0.880
Why?
Follow-Up Studies
26
2024
2190
0.880
Why?
Plasma Cells
11
2023
223
0.860
Why?
Hyperhidrosis
1
2022
2
0.850
Why?
Sweat
1
2022
7
0.840
Why?
Survival Rate
24
2020
901
0.820
Why?
Lymphoma, B-Cell
3
2022
63
0.810
Why?
Drug Approval
1
2022
47
0.800
Why?
Ehrlichia chaffeensis
1
2021
4
0.770
Why?
Patient Participation
1
2022
66
0.770
Why?
Ehrlichiosis
1
2021
15
0.760
Why?
Cryosurgery
1
2021
36
0.760
Why?
T-Lymphocytes
8
2024
339
0.760
Why?
Immunoglobulin Light Chains
3
2017
82
0.750
Why?
Lymphohistiocytosis, Hemophagocytic
1
2021
26
0.740
Why?
Embolization, Therapeutic
1
2021
86
0.710
Why?
Disease Progression
16
2023
831
0.690
Why?
Cell Proliferation
10
2023
1013
0.690
Why?
Chromosomal Instability
1
2019
16
0.680
Why?
Neoplasms, Plasma Cell
3
2024
37
0.660
Why?
Membrane Proteins
3
2006
353
0.660
Why?
Adrenal Cortex Hormones
2
2023
94
0.650
Why?
Immunologic Factors
2
2018
114
0.640
Why?
Neoplasm, Residual
8
2022
165
0.630
Why?
Epigenesis, Genetic
4
2023
378
0.630
Why?
Tumor Microenvironment
6
2024
233
0.620
Why?
Chromosome Aberrations
12
2023
297
0.610
Why?
POEMS Syndrome
1
2018
32
0.610
Why?
Atrial Fibrillation
2
2022
183
0.610
Why?
Dendritic Cells
3
2014
133
0.610
Why?
Survival Analysis
17
2023
666
0.600
Why?
Thyroid Neoplasms
1
2019
111
0.590
Why?
Polymorphism, Single Nucleotide
3
2024
485
0.580
Why?
Prealbumin
2
2014
21
0.580
Why?
Antibodies, Monoclonal, Humanized
6
2023
225
0.570
Why?
Positron-Emission Tomography
7
2022
294
0.560
Why?
Receptors, Interleukin-6
2
2014
22
0.560
Why?
Cardiomyopathies
2
2014
116
0.530
Why?
Mutation
10
2022
1294
0.510
Why?
Aged, 80 and over
19
2024
3154
0.510
Why?
Osteolysis
4
2022
75
0.490
Why?
Immunotoxins
1
2014
6
0.480
Why?
Drug Resistance, Neoplasm
7
2024
314
0.470
Why?
Cytotoxicity, Immunologic
2
2012
55
0.470
Why?
Recurrence
13
2024
662
0.470
Why?
Clonal Evolution
3
2020
56
0.460
Why?
Practice Guidelines as Topic
4
2023
449
0.460
Why?
Cyclophosphamide
5
2021
166
0.440
Why?
Transplantation, Homologous
5
2017
138
0.440
Why?
Amyloidosis
1
2014
81
0.440
Why?
Health Status
1
2015
296
0.430
Why?
Fluorodeoxyglucose F18
6
2021
194
0.420
Why?
Genome-Wide Association Study
3
2024
166
0.410
Why?
Remission Induction
13
2021
207
0.410
Why?
Risk Factors
18
2021
3629
0.410
Why?
Neutropenia
2
2023
115
0.400
Why?
Receptors, KIR
2
2008
13
0.400
Why?
Genetic Predisposition to Disease
3
2024
509
0.390
Why?
Pyrimidines
2
2022
193
0.380
Why?
Bone Diseases
3
2021
99
0.380
Why?
Dose-Response Relationship, Drug
8
2020
1378
0.380
Why?
Thrombocytopenia
2
2022
84
0.370
Why?
Azacitidine
1
2010
34
0.370
Why?
Benzamides
1
2010
51
0.370
Why?
Evolution, Molecular
2
2021
99
0.360
Why?
Histone Deacetylase Inhibitors
1
2010
56
0.360
Why?
C-Reactive Protein
6
2022
143
0.350
Why?
Prednisone
2
2021
101
0.350
Why?
Doxorubicin
6
2021
239
0.350
Why?
TOR Serine-Threonine Kinases
2
2020
77
0.340
Why?
Drug Administration Schedule
5
2015
377
0.340
Why?
Chromosome Deletion
5
2023
140
0.330
Why?
Vaccination
4
2022
271
0.330
Why?
Metaphase
4
2016
44
0.330
Why?
Pelvis
2
2021
67
0.330
Why?
Quality of Life
1
2015
839
0.330
Why?
Membrane Glycoproteins
2
2009
246
0.320
Why?
Paraproteinemias
3
2022
72
0.320
Why?
Proportional Hazards Models
7
2024
410
0.310
Why?
Animals
15
2024
13246
0.310
Why?
Placebo Effect
2
2020
17
0.310
Why?
Bone Neoplasms
4
2013
183
0.300
Why?
Adoptive Transfer
1
2007
40
0.300
Why?
Histocompatibility Antigens Class I
1
2007
44
0.300
Why?
Chromatin
3
2023
152
0.290
Why?
CD8-Positive T-Lymphocytes
3
2024
128
0.290
Why?
Cytogenetic Analysis
5
2023
82
0.290
Why?
DNA Methylation
4
2023
550
0.280
Why?
Boron Compounds
2
2024
19
0.280
Why?
Risk Assessment
9
2022
1262
0.280
Why?
Chromans
2
2024
36
0.280
Why?
Vincristine
3
2021
88
0.280
Why?
Mice, SCID
6
2013
176
0.280
Why?
Cell Membrane
1
2007
251
0.280
Why?
Glycine
2
2024
75
0.270
Why?
Down-Regulation
1
2007
349
0.270
Why?
Angiogenesis Inhibitors
5
2010
188
0.270
Why?
In Situ Hybridization, Fluorescence
5
2023
259
0.270
Why?
Neoplasm Staging
6
2024
738
0.260
Why?
Disease Management
2
2018
176
0.260
Why?
Cell Line, Tumor
9
2023
1416
0.260
Why?
Chromosomes, Human, Pair 17
2
2017
36
0.260
Why?
Vitamin E
2
2024
79
0.260
Why?
Case-Control Studies
6
2024
1126
0.260
Why?
Transplantation Conditioning
5
2008
84
0.260
Why?
Infusions, Intravenous
3
2015
213
0.250
Why?
Mice
11
2024
5759
0.250
Why?
Bone Resorption
2
2022
302
0.250
Why?
Antibody Formation
1
2005
52
0.250
Why?
Fever
2
2022
115
0.240
Why?
Registries
3
2024
522
0.240
Why?
Polycomb Repressive Complex 2
2
2021
47
0.240
Why?
Time Factors
11
2021
2922
0.240
Why?
Flow Cytometry
4
2012
476
0.230
Why?
Monocytes
2
2020
131
0.230
Why?
Gene Expression
2
2018
609
0.230
Why?
High-Throughput Nucleotide Sequencing
3
2022
170
0.230
Why?
Ubiquitin-Protein Ligases
1
2024
95
0.220
Why?
Cell Cycle Proteins
2
2022
166
0.220
Why?
Blotting, Western
3
2015
601
0.220
Why?
Proteasome Endopeptidase Complex
3
2011
117
0.220
Why?
Epstein-Barr Virus Infections
2
2020
30
0.220
Why?
Signal Transduction
6
2021
1622
0.220
Why?
Integrin beta Chains
1
2023
14
0.220
Why?
Radiation-Protective Agents
1
2024
74
0.220
Why?
Prospective Studies
8
2022
2379
0.220
Why?
Integrins
1
2023
31
0.220
Why?
Young Adult
5
2020
3981
0.210
Why?
Cross-Sectional Studies
3
2023
1554
0.210
Why?
Double-Blind Method
2
2015
688
0.210
Why?
Sweating
1
2022
7
0.210
Why?
Hematopoietic Stem Cells
2
2022
184
0.210
Why?
Consensus
2
2020
150
0.210
Why?
Proto-Oncogene Proteins B-raf
2
2020
79
0.210
Why?
Tumor Suppressor Protein p53
2
2017
203
0.210
Why?
DNA, Intergenic
1
2022
7
0.200
Why?
Kaplan-Meier Estimate
10
2016
465
0.200
Why?
Tumor Cells, Cultured
4
2013
468
0.200
Why?
Receptors, Antigen, T-Cell
1
2022
51
0.200
Why?
Immunoconjugates
1
2022
38
0.200
Why?
United States
4
2022
4874
0.200
Why?
Waldenstrom Macroglobulinemia
1
2022
40
0.200
Why?
Proteomics
3
2021
330
0.200
Why?
United States Food and Drug Administration
1
2022
91
0.200
Why?
Influenza, Human
1
2022
84
0.200
Why?
Mediastinum
1
2021
21
0.190
Why?
Epigenomics
1
2021
68
0.190
Why?
Chromosomes, Human, Pair 14
3
2020
75
0.190
Why?
Receptors, Glucocorticoid
2
2012
32
0.190
Why?
Phosphatidylinositol 3-Kinases
2
2019
140
0.190
Why?
Ubiquitination
1
2021
43
0.190
Why?
Axilla
1
2021
90
0.190
Why?
Alleles
3
2021
251
0.190
Why?
Apoptosis
5
2018
1112
0.190
Why?
Multiple Organ Failure
1
2021
47
0.190
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
92
0.190
Why?
Proto-Oncogene Proteins c-maf
2
2020
19
0.190
Why?
Diffusion Magnetic Resonance Imaging
2
2019
124
0.190
Why?
Salvage Therapy
6
2013
139
0.190
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
106
0.190
Why?
Epstein-Barr Virus Nuclear Antigens
1
2020
1
0.190
Why?
Rare Diseases
1
2020
44
0.180
Why?
Interferon-gamma
3
2014
176
0.180
Why?
Genes, Tumor Suppressor
2
2021
73
0.180
Why?
Longitudinal Studies
5
2024
695
0.180
Why?
Radiopharmaceuticals
4
2021
208
0.180
Why?
Cytokines
2
2014
613
0.180
Why?
Cell Cycle
1
2021
232
0.180
Why?
Interferon Type I
1
2020
25
0.180
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.180
Why?
Myelodysplastic Syndromes
2
2013
81
0.180
Why?
Leukemia, Plasma Cell
1
2020
33
0.180
Why?
Research Design
2
2020
342
0.170
Why?
Multivariate Analysis
8
2021
581
0.170
Why?
Gene Amplification
1
2019
57
0.170
Why?
Health Status Disparities
1
2022
194
0.170
Why?
Measles virus
1
2019
8
0.170
Why?
Genomics
4
2023
285
0.170
Why?
Measles
1
2019
7
0.170
Why?
Gene Regulatory Networks
1
2020
107
0.170
Why?
Data Collection
1
2020
277
0.170
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.170
Why?
DNA
1
2023
541
0.170
Why?
Immunohistochemistry
2
2015
978
0.170
Why?
Oncolytic Virotherapy
1
2019
17
0.170
Why?
Biopsy
5
2018
590
0.170
Why?
Patient Safety
1
2020
102
0.160
Why?
Sirolimus
1
2019
62
0.160
Why?
Healthcare Disparities
1
2022
268
0.160
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.160
Why?
Cell Differentiation
6
2022
650
0.160
Why?
Precancerous Conditions
2
2010
83
0.160
Why?
Proto-Oncogene Proteins c-akt
1
2019
157
0.160
Why?
Evidence-Based Medicine
2
2018
247
0.160
Why?
Syndrome
1
2019
238
0.160
Why?
Graft vs Host Disease
4
2007
75
0.160
Why?
MafB Transcription Factor
1
2018
9
0.160
Why?
Spleen
1
2019
172
0.160
Why?
Phosphotransferases
1
2018
16
0.160
Why?
Genomic Instability
2
2016
93
0.150
Why?
Immunomodulation
1
2018
37
0.150
Why?
Plasma
1
2018
42
0.150
Why?
Chemokines
1
2018
78
0.150
Why?
Myeloablative Agonists
2
2008
30
0.150
Why?
Hematopoietic Stem Cell Mobilization
2
2008
57
0.150
Why?
Genes, Neoplasm
2
2015
30
0.150
Why?
Adipocytes
1
2018
121
0.150
Why?
Magnetic Resonance Imaging
5
2013
1541
0.150
Why?
Osteoclasts
3
2022
428
0.150
Why?
Models, Biological
2
2018
723
0.150
Why?
Gene Dosage
2
2015
78
0.150
Why?
Gene Rearrangement
1
2018
74
0.150
Why?
Hexokinase
1
2017
17
0.150
Why?
Communication
1
2019
246
0.140
Why?
Heterozygote
2
2014
81
0.140
Why?
HLA-A Antigens
2
2007
10
0.140
Why?
Calcification, Physiologic
1
2017
41
0.140
Why?
Protein-Tyrosine Kinases
2
2018
95
0.140
Why?
Drug Therapy, Combination
1
2018
381
0.140
Why?
Retrospective Studies
8
2024
6134
0.140
Why?
Oligonucleotide Array Sequence Analysis
5
2010
411
0.140
Why?
Gene Frequency
2
2013
94
0.140
Why?
Transcriptome
4
2020
320
0.130
Why?
Syndecan-1
4
2021
72
0.130
Why?
Critical Illness
1
2018
288
0.130
Why?
Gene Expression Regulation, Enzymologic
1
2017
180
0.130
Why?
Lymphocyte Activation
2
2017
172
0.130
Why?
Confidence Intervals
2
2014
156
0.130
Why?
Tumor Burden
3
2020
131
0.130
Why?
Adolescent
5
2020
6390
0.130
Why?
Immunity, Innate
1
2016
105
0.130
Why?
Erythrocyte Indices
1
2015
7
0.130
Why?
Biomarkers, Pharmacological
2
2012
25
0.130
Why?
DNA Copy Number Variations
3
2022
110
0.130
Why?
Coculture Techniques
2
2013
146
0.130
Why?
Hemoglobins
2
2013
107
0.120
Why?
Cysteine-Rich Protein 61
1
2014
3
0.120
Why?
International Cooperation
1
2014
44
0.120
Why?
Hematologic Diseases
1
2014
22
0.120
Why?
Half-Life
1
2014
87
0.120
Why?
Fatigue
1
2015
117
0.120
Why?
Enzyme-Linked Immunosorbent Assay
1
2015
244
0.120
Why?
Iron
1
2015
122
0.120
Why?
Area Under Curve
1
2014
178
0.120
Why?
Amyloid Neuropathies, Familial
1
2013
5
0.120
Why?
Antibodies
2
2024
154
0.120
Why?
Reference Values
1
2014
310
0.110
Why?
ROC Curve
1
2014
232
0.110
Why?
Severity of Illness Index
2
2014
951
0.110
Why?
Emotions
1
2015
164
0.110
Why?
Renal Insufficiency
2
2021
109
0.110
Why?
Antineoplastic Agents, Alkylating
3
2008
74
0.110
Why?
Neoplasms, Glandular and Epithelial
1
2014
42
0.110
Why?
Disease Models, Animal
2
2016
1458
0.110
Why?
Administration, Metronomic
1
2013
7
0.110
Why?
Cystatin M
2
2024
20
0.110
Why?
Inflammation Mediators
1
2014
113
0.110
Why?
Cisplatin
4
2013
278
0.110
Why?
Macaca mulatta
2
2024
93
0.110
Why?
Nicotinamide Phosphoribosyltransferase
1
2013
5
0.110
Why?
Central Nervous System Neoplasms
1
2013
64
0.110
Why?
Oligopeptides
1
2013
91
0.110
Why?
beta Catenin
1
2013
102
0.110
Why?
Lymph Nodes
3
2021
263
0.110
Why?
Antibody-Dependent Cell Cytotoxicity
2
2009
12
0.110
Why?
Venous Thrombosis
2
2004
90
0.110
Why?
Myelolipoma
1
2012
9
0.110
Why?
Leukemia
1
2013
65
0.110
Why?
Mental Health
1
2015
220
0.100
Why?
Cell Survival
2
2020
602
0.100
Why?
Interleukin Receptor Common gamma Subunit
1
2012
8
0.100
Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
9
0.100
Why?
Clone Cells
2
2023
78
0.100
Why?
Maintenance Chemotherapy
1
2012
49
0.100
Why?
Pain
1
2015
381
0.100
Why?
Adaptor Proteins, Signal Transducing
2
2024
198
0.100
Why?
Interleukin-2
1
2012
72
0.100
Why?
Models, Genetic
2
2016
170
0.100
Why?
Vascular Endothelial Growth Factor A
1
2013
202
0.100
Why?
Mice, Inbred NOD
1
2012
96
0.100
Why?
Cell Movement
1
2013
249
0.100
Why?
Immunoenzyme Techniques
1
2012
145
0.100
Why?
Hemangioma
1
2013
83
0.100
Why?
Soft Tissue Neoplasms
1
2012
57
0.100
Why?
Genotype
1
2013
534
0.100
Why?
Arkansas
5
2021
1985
0.100
Why?
Transcriptional Elongation Factors
2
2022
18
0.090
Why?
Transduction, Genetic
2
2014
45
0.090
Why?
Chemokine CXCL13
2
2022
5
0.090
Why?
Models, Statistical
2
2014
224
0.090
Why?
Peripheral Blood Stem Cell Transplantation
2
2008
53
0.090
Why?
Mutation Rate
2
2021
36
0.090
Why?
Immunoglobulin Idiotypes
1
2010
5
0.090
Why?
CD40 Ligand
1
2010
14
0.090
Why?
Hypersensitivity, Delayed
1
2010
21
0.090
Why?
Secondary Prevention
1
2010
78
0.090
Why?
Interleukin-4
1
2010
43
0.090
Why?
Up-Regulation
4
2018
453
0.090
Why?
HIV Seropositivity
1
2010
27
0.090
Why?
Eukaryotic Initiation Factor-2
1
2010
18
0.090
Why?
Adjuvants, Immunologic
1
2010
51
0.090
Why?
Immunity, Cellular
1
2010
70
0.090
Why?
Cell Line
2
2013
1021
0.090
Why?
Cells, Cultured
3
2013
1581
0.090
Why?
Etoposide
2
2007
72
0.090
Why?
Ovarian Neoplasms
1
2014
447
0.080
Why?
Placenta
1
2011
132
0.080
Why?
Transplantation, Heterologous
1
2009
75
0.080
Why?
Radiography
4
2012
491
0.080
Why?
Hospitalization
2
2024
655
0.080
Why?
Polymerase Chain Reaction
1
2010
454
0.080
Why?
Cytotoxicity Tests, Immunologic
1
2008
28
0.080
Why?
Histones
2
2021
313
0.080
Why?
Transcription Factors
2
2023
564
0.080
Why?
Bone and Bones
3
2021
475
0.080
Why?
Lymphocyte Subsets
1
2008
13
0.080
Why?
Haplotypes
1
2008
84
0.080
Why?
Immunoglobulin lambda-Chains
1
2008
15
0.080
Why?
Granulocyte Colony-Stimulating Factor
1
2008
61
0.080
Why?
Liver Neoplasms
1
2012
328
0.080
Why?
Cytogenetics
1
2008
23
0.080
Why?
Gene Deletion
1
2009
270
0.080
Why?
Receptors, Immunologic
1
2008
37
0.080
Why?
Ligands
1
2008
205
0.080
Why?
Neoplastic Stem Cells
1
2009
103
0.080
Why?
Osteogenesis
1
2011
353
0.080
Why?
Twins
1
2007
33
0.080
Why?
Busulfan
1
2007
19
0.070
Why?
Herpesviridae Infections
2
2019
46
0.070
Why?
Diphosphonates
1
2008
90
0.070
Why?
Immunophenotyping
1
2007
109
0.070
Why?
Leukocytes, Mononuclear
1
2007
115
0.070
Why?
Caspases
2
2018
104
0.070
Why?
Antimetabolites
1
2006
13
0.070
Why?
Creatinine
1
2007
141
0.070
Why?
Blood Proteins
1
2007
82
0.070
Why?
Immunosuppressive Agents
1
2008
222
0.070
Why?
Antibodies, Neoplasm
1
2006
28
0.070
Why?
Skin Neoplasms
1
2012
492
0.070
Why?
Graft vs Leukemia Effect
1
2006
2
0.070
Why?
Chromosome Banding
1
2006
24
0.070
Why?
Plasmacytoma
1
2006
42
0.070
Why?
Cohort Studies
3
2020
1422
0.070
Why?
MicroRNAs
1
2010
355
0.070
Why?
Amiloride
1
2005
8
0.070
Why?
HLA-A2 Antigen
1
2005
11
0.070
Why?
Bone Marrow Transplantation
2
2022
116
0.070
Why?
Imaging, Three-Dimensional
2
2017
153
0.070
Why?
Sensitivity and Specificity
1
2007
863
0.060
Why?
Predictive Value of Tests
3
2018
905
0.060
Why?
Tomography, X-Ray Computed
2
2023
1161
0.060
Why?
Poly(ADP-ribose) Polymerases
2
2016
30
0.060
Why?
Transmembrane Activator and CAML Interactor Protein
1
2024
6
0.060
Why?
Mendelian Randomization Analysis
1
2024
7
0.060
Why?
Phthalimides
1
2024
4
0.060
Why?
Piperidones
1
2024
5
0.060
Why?
Enoxaparin
1
2004
27
0.060
Why?
Telomere
1
2024
36
0.060
Why?
Retreatment
1
2024
56
0.060
Why?
Ferritins
1
2024
30
0.060
Why?
NF-kappa B
2
2018
315
0.060
Why?
Morpholines
1
2024
70
0.060
Why?
Myeloid Progenitor Cells
1
2023
18
0.060
Why?
X-Ray Microtomography
1
2024
77
0.060
Why?
Cost of Illness
1
2024
117
0.060
Why?
Receptors, G-Protein-Coupled
1
2024
53
0.060
Why?
Neoplasms
1
2014
1249
0.060
Why?
Epidemiologic Methods
3
2008
49
0.060
Why?
DNA, Neoplasm
2
2020
147
0.060
Why?
Fibroblasts
1
2005
351
0.060
Why?
Gene Silencing
2
2016
118
0.060
Why?
Cell Communication
1
2023
69
0.050
Why?
Cluster Analysis
3
2010
235
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Patients
1
2022
49
0.050
Why?
Geography
1
2022
60
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
33
0.050
Why?
Guanine Nucleotide Exchange Factors
1
2022
18
0.050
Why?
Whole-Body Irradiation
1
2022
131
0.050
Why?
Inheritance Patterns
1
2022
22
0.050
Why?
Quantitative Trait Loci
1
2022
42
0.050
Why?
Primary Cell Culture
1
2022
61
0.050
Why?
Patient Selection
1
2023
253
0.050
Why?
Chromosomal Proteins, Non-Histone
1
2022
40
0.050
Why?
Oncogenes
1
2021
57
0.050
Why?
Risk
2
2014
324
0.050
Why?
Anticoagulants
1
2004
253
0.050
Why?
Phylogeny
1
2022
234
0.050
Why?
Age of Onset
2
2013
107
0.050
Why?
Child, Preschool
2
2020
3883
0.050
Why?
RANK Ligand
1
2022
179
0.050
Why?
SOXC Transcription Factors
1
2021
13
0.050
Why?
Rabbits
2
2013
374
0.050
Why?
Polymorphism, Genetic
1
2022
181
0.050
Why?
Transcriptional Activation
1
2021
121
0.050
Why?
Fibrosis
1
2021
180
0.050
Why?
Edema
1
2021
69
0.050
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
66
0.050
Why?
Cyclin D2
1
2020
20
0.050
Why?
Aneuploidy
1
2020
16
0.050
Why?
Spatio-Temporal Analysis
1
2020
10
0.050
Why?
Base Sequence
1
2022
644
0.050
Why?
Repressor Proteins
1
2022
153
0.050
Why?
Chromosomes, Human, Pair 4
1
2020
31
0.050
Why?
Gene Expression Regulation, Leukemic
1
2020
33
0.050
Why?
Chromosomes, Human, Pair 11
1
2020
54
0.050
Why?
Histone Code
1
2020
32
0.050
Why?
Cyclin D1
1
2020
56
0.050
Why?
ras Proteins
1
2020
64
0.050
Why?
Genome, Human
1
2021
111
0.050
Why?
Protein Kinase Inhibitors
1
2022
206
0.040
Why?
Single-Cell Analysis
1
2020
61
0.040
Why?
Genetic Loci
1
2020
49
0.040
Why?
Mice, Transgenic
1
2021
550
0.040
Why?
False Negative Reactions
1
2019
30
0.040
Why?
Genetic Variation
1
2020
213
0.040
Why?
DNA Mutational Analysis
1
2020
176
0.040
Why?
Neoplasm Invasiveness
1
2020
266
0.040
Why?
Incidence
2
2013
1006
0.040
Why?
Herpesvirus 4, Human
1
2019
35
0.040
Why?
Europe
1
2019
76
0.040
Why?
Communicable Disease Control
1
2019
39
0.040
Why?
beta 2-Microglobulin
2
2009
38
0.040
Why?
RNA, Messenger
2
2016
1108
0.040
Why?
Computational Biology
1
2020
216
0.040
Why?
Virus Diseases
1
2019
40
0.040
Why?
Genome, Viral
1
2019
79
0.040
Why?
DNA, Viral
1
2019
134
0.040
Why?
Fibrinogen
1
2018
32
0.040
Why?
Immunoglobulin A
1
2018
45
0.040
Why?
Glycogen Synthase Kinase 3
1
2018
20
0.040
Why?
Bone Marrow Cells
2
2014
190
0.040
Why?
Platelet Count
2
2008
72
0.040
Why?
Pathology, Molecular
1
2018
22
0.040
Why?
DNA-Binding Proteins
1
2021
428
0.040
Why?
Promoter Regions, Genetic
1
2020
475
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
51
0.040
Why?
Immunoglobulin G
1
2018
186
0.040
Why?
Oncogene Proteins, Fusion
1
2018
58
0.040
Why?
Data Interpretation, Statistical
2
2010
157
0.040
Why?
Databases, Factual
2
2013
657
0.040
Why?
Child
2
2020
6851
0.040
Why?
Kidney Function Tests
1
2017
49
0.040
Why?
False Positive Reactions
1
2017
62
0.040
Why?
Glomerular Filtration Rate
1
2017
111
0.040
Why?
Lamins
1
2016
5
0.040
Why?
Cell Transformation, Neoplastic
1
2018
179
0.040
Why?
Chromosomes, Human, Pair 16
1
2016
19
0.040
Why?
Internationality
1
2017
36
0.040
Why?
Amino Acid Sequence
1
2018
586
0.030
Why?
Alkaline Phosphatase
1
2017
95
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Genes, p53
1
2016
51
0.030
Why?
Lymphocytes, Tumor-Infiltrating
1
2017
78
0.030
Why?
Glycolysis
1
2016
70
0.030
Why?
Proteolysis
1
2016
95
0.030
Why?
Enzyme Activation
1
2016
275
0.030
Why?
Chromosome Mapping
2
2006
156
0.030
Why?
Prevalence
1
2019
951
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
106
0.030
Why?
Phosphorylation
1
2016
534
0.030
Why?
Kidney Diseases
1
2017
214
0.030
Why?
Myocardium
1
2017
438
0.030
Why?
Asymptomatic Diseases
1
2014
36
0.030
Why?
Gene Fusion
1
2014
9
0.030
Why?
Interspersed Repetitive Sequences
1
2014
8
0.030
Why?
Karyotype
1
2014
18
0.030
Why?
Capsid
1
2014
3
0.030
Why?
Lymphocyte Culture Test, Mixed
1
2014
7
0.030
Why?
HIV-1
1
2014
55
0.030
Why?
Homozygote
1
2013
57
0.030
Why?
Cerebrospinal Fluid
1
2013
32
0.030
Why?
Genetic Vectors
1
2014
125
0.030
Why?
Nicotinamide Mononucleotide
1
2013
3
0.030
Why?
Acrylamides
1
2013
6
0.030
Why?
Receptors, CXCR4
1
2013
28
0.030
Why?
Diagnosis, Differential
1
2017
1043
0.030
Why?
Niacinamide
1
2013
22
0.030
Why?
Dependovirus
1
2014
101
0.030
Why?
NAD
1
2013
43
0.030
Why?
Enzyme Induction
1
2013
79
0.030
Why?
Amides
1
2013
39
0.030
Why?
Sirtuin 1
1
2013
28
0.030
Why?
Chemokine CXCL12
1
2013
32
0.030
Why?
Nitriles
1
2013
54
0.030
Why?
Gene Knockdown Techniques
1
2013
106
0.030
Why?
Transplantation Chimera
2
2003
15
0.030
Why?
RNA, Small Interfering
1
2013
215
0.030
Why?
Infant
1
2020
3563
0.030
Why?
Piperidines
1
2013
98
0.030
Why?
Induction Chemotherapy
1
2012
60
0.030
Why?
Lymphocyte Count
1
2011
22
0.030
Why?
Acute Disease
1
2013
368
0.030
Why?
Chemokine CXCL10
1
2011
19
0.030
Why?
HIV Infections
1
2016
357
0.030
Why?
Antibodies, Neutralizing
1
2011
64
0.020
Why?
Sex Factors
1
2013
697
0.020
Why?
Pharmacogenetics
1
2011
52
0.020
Why?
Clinical Trials, Phase I as Topic
1
2010
25
0.020
Why?
Clinical Trials, Phase II as Topic
1
2010
44
0.020
Why?
Clinical Trials, Phase III as Topic
1
2010
43
0.020
Why?
Microarray Analysis
1
2010
73
0.020
Why?
Enzyme Inhibitors
1
2013
386
0.020
Why?
International Classification of Diseases
1
2010
64
0.020
Why?
Argonaute Proteins
1
2010
11
0.020
Why?
RNA-Binding Proteins
1
2011
123
0.020
Why?
Oligonucleotides
1
2010
81
0.020
Why?
Polyploidy
1
2009
11
0.020
Why?
Bone Marrow Examination
1
2009
11
0.020
Why?
L-Lactate Dehydrogenase
1
2009
66
0.020
Why?
Ploidies
1
2008
11
0.020
Why?
Neoplasm Metastasis
1
2009
236
0.020
Why?
Chromosomes, Human, Pair 13
1
2008
38
0.020
Why?
Serum Albumin
1
2008
58
0.020
Why?
Polyethylene Glycols
1
2008
93
0.020
Why?
Randomized Controlled Trials as Topic
1
2010
550
0.020
Why?
Xenograft Model Antitumor Assays
1
2008
212
0.020
Why?
Age Distribution
1
2007
168
0.020
Why?
Antineoplastic Agents, Hormonal
1
2007
48
0.020
Why?
Recombinant Proteins
1
2008
487
0.020
Why?
Multigene Family
1
2006
56
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Syndecans
1
2006
34
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
RNA, Neoplasm
1
2006
45
0.020
Why?
Proteoglycans
1
2006
80
0.020
Why?
Leukemia, Myeloid, Acute
1
2007
185
0.020
Why?
Brain
1
2013
1328
0.020
Why?
Survivors
1
2006
125
0.020
Why?
Pregnancy
1
2011
2604
0.010
Why?
Lymphocyte Transfusion
1
2003
10
0.010
Why?
Probability
1
2003
164
0.010
Why?
Administration, Oral
1
2003
434
0.010
Why?
Tissue Donors
1
2003
113
0.010
Why?
Van Rhee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description